Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Jacksonville › NPI 1447206438
Hospital

Memorial Healthcare Group INC

Memorial Healthcare Group INC was paid $19.43M by Medicaid between Jan 2018 and Dec 2024, across 206 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.

33Billing provider infoMEMORIAL HEALTHCARE GROUP INC
JACKSONVILLE, FL 32216
33aNPI1447206438assigned 05/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.43M
24GClaims657,643
24DCodes billed206
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#16 of 163
Median peer was paid$4.77M
This provider vs. median4.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201861,872$729K
2019150,460$3.28M
2020109,273$2.83M
2021120,971$3.89M
2022124,345$4.64M
202363,243$2.65M
2024incomplete27,479$1.41M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 32% 74,864 68,469 $6.29M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 41,529 36,507 $2.77M
80053 Comprehensive metabolic panel 6.5% 29,689 24,272 $1.26M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.9% 12,343 8,000 $950K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.2% 11,895 11,190 $823K
70450 Computed tomography, head or brain; without contrast material 3.6% 7,092 6,151 $699K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.4% 4,706 4,338 $668K
80048 Basic metabolic panel (calcium, ionized) 3.4% 12,632 8,712 $654K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.4% 4,713 4,388 $469K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility 2.0% 1,846 251 $382K
71275 Computed tomographic angiography, chest, with contrast material 1.8% 1,877 1,708 $358K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.7% 2,603 2,348 $328K
194 more codes
81003 1.2% 33,585 $237K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 2,231 $172K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,585 $162K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,941 $146K
G0378 Hospital observation service, per hour <1% 8,134 $138K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,416 $135K
96361 Intravenous infusion, hydration; each additional hour <1% 1,061 $130K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 1,623 $126K
87070 <1% 7,818 $121K
72125 Computed tomography, cervical spine; without contrast material <1% 2,508 $119K
80305 <1% 5,341 $107K
71045 Radiologic examination, chest; single view <1% 16,402 $96K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,046 $85K
84702 <1% 4,256 $85K
10060 <1% 904 $78K
85027 <1% 43,561 $72K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 6,158 $65K
87169 <1% 3,242 $63K
86850 <1% 1,492 $60K
71046 Radiologic examination, chest; 2 views <1% 4,578 $60K
A9270 Non-covered item or service <1% 11,104 $58K
81025 <1% 15,579 $53K
12001 <1% 570 $51K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,228 $50K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,418 $44K
87088 <1% 5,121 $44K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,475 $40K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 204 $39K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 295 $35K
73610 <1% 995 $35K
87077 <1% 2,255 $33K
76801 <1% 3,109 $31K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,111 $29K
76830 Ultrasound, transvaginal <1% 1,240 $29K
85610 <1% 6,758 $27K
73630 <1% 959 $26K
72131 <1% 808 $26K
J1644 Injection, heparin sodium, per 1000 units <1% 4,982 $25K
70486 <1% 504 $24K
12011 <1% 261 $24K
73030 <1% 1,214 $23K
82565 <1% 310 $23K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,832 $23K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 998 $22K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,563 $22K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 16,117 $21K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,470 $21K
73564 <1% 951 $21K
J2704 Injection, propofol, 10 mg <1% 1,284 $20K
73130 <1% 699 $19K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 17,469 $19K
74018 <1% 1,135 $17K
93971 <1% 1,117 $17K
86900 <1% 3,016 $16K
84484 <1% 10,238 $16K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,108 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 9,812 $16K
73560 <1% 673 $16K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,747 $15K
J7030 Infusion, normal saline solution , 1000 cc <1% 11,884 $14K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 790 $14K
80047 <1% 350 $13K
84703 <1% 2,441 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,831 $12K
73620 <1% 400 $12K
93458 <1% 43 $11K
76818 <1% 196 $11K
85730 <1% 5,390 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 80 $11K
J3490 Unclassified drugs <1% 413 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,560 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,739 $10K
73140 <1% 205 $9K
72040 <1% 285 $9K
80076 <1% 465 $9K
77067 Screening mammography, bilateral, including computer-aided detection <1% 606 $8K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,133 $8K
84132 <1% 377 $8K
12002 <1% 111 $8K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 13 $8K
J0690 Injection, cefazolin sodium, 500 mg <1% 376 $7K
84112 <1% 55 $7K
C1769 Guide wire <1% 554 $7K
71250 <1% 212 $7K
80061 Lipid panel <1% 1,094 $6K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 100 $6K
87807 <1% 1,818 $6K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,024 $6K
73110 <1% 241 $6K
77063 Screening digital breast tomosynthesis, bilateral <1% 473 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,654 $5K
83880 <1% 2,769 $5K
G0381 Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 113 $5K
83735 <1% 3,523 $5K
73090 <1% 141 $5K
72100 <1% 260 $5K
93017 <1% 262 $5K
84443 Thyroid stimulating hormone (TSH) <1% 2,941 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,160 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 29 $4K
85379 <1% 1,728 $4K
72128 <1% 146 $4K
93798 <1% 103 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,816 $4K
83690 <1% 9,681 $4K
93970 <1% 204 $4K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 102 $4K
76642 <1% 55 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,464 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 1,755 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,596 $3K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 81 $3K
82805 <1% 28 $3K
85014 <1% 300 $3K
87040 <1% 1,827 $3K
93976 <1% 113 $2K
73100 <1% 114 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 5,961 $2K
72110 <1% 168 $2K
82553 <1% 918 $2K
73600 <1% 71 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,540 $2K
73120 <1% 70 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,036 $2K
86140 <1% 940 $2K
73502 <1% 211 $2K
29125 <1% 47 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 837 $1K
80320 <1% 893 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,264 $1K
73080 <1% 42 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,151 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,538 $1K
86901 <1% 2,870 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 477 $1K
87210 <1% 2,781 $1K
73590 <1% 138 $1K
84439 <1% 702 $1K
93312 <1% 15 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,917 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 776 $1K
90714 <1% 1,225 $1K
80329 <1% 667 $862.66
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 300 $802.66
83605 <1% 1,697 $800.22
84100 <1% 1,262 $798.88
87186 <1% 1,956 $752.18
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 488 $676.21
85018 <1% 271 $581.42
88342 <1% 121 $578.45
J3370 Injection, vancomycin hcl, 500 mg <1% 339 $567.61
82550 <1% 1,444 $537.59
J7999 Compounded drug, not otherwise classified <1% 287 $439.09
72170 <1% 13 $425.69
P9016 Red blood cells, leukocytes reduced, each unit <1% 17 $405.26
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 35 $389.20
93325 <1% 15 $386.19
J7050 Infusion, normal saline solution, 250 cc <1% 1,095 $365.41
76775 <1% 14 $319.38
J1815 Injection, insulin, per 5 units <1% 2,361 $297.69
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 173 $288.56
82010 <1% 14 $228.10
72070 <1% 13 $187.97
85651 <1% 451 $174.29
87400 <1% 4,233 $168.88
97163 <1% 64 $130.19
82607 <1% 31 $129.26
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 21 $128.58
97162 <1% 15 $128.58
J2060 Injection, lorazepam, 2 mg <1% 1,196 $126.59
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 111 $120.00
J2785 Injection, regadenoson, 0.1 mg <1% 71 $120.00
93880 <1% 13 $98.16
87147 <1% 46 $96.40
96376 <1% 542 $59.99
J8540 Dexamethasone, oral, 0.25 mg <1% 572 $25.83
82728 <1% 63 $15.68
90686 <1% 26 $14.32
83550 <1% 93 $7.84
82077 <1% 862 $7.62
83540 <1% 96 $6.72
Q9957 Injection, perflutren lipid microspheres, per ml <1% 15 $5.20
86920 <1% 19 $4.17
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 462 $1.06
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 1,316 $0.00
00731 0% 29 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 17 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 54 $0.00
76937 0% 14 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 258 $0.00
87205 0% 101 $0.00
74021 0% 13 $0.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 0% 14 $0.00
82746 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARTMANN, DREW (CFO)